Eton Pharmaceuticals, Inc. (NASDAQ:ETON) headquartered in Deer Park, will host a conference call for the investment community to discuss the 2Q20 earnings result on 12th August 2020 at 4:30 PM Eastern Time.
Those interested in listening to the conference call live via the Internet can visit www.etonpharma.com
Earnings Expectation
Eton Pharmaceuticals, Inc. is reporting second quarter earnings results on Wednesday 12th August 2020, after market close. The consensus estimates from Thomson Reuters are loss of $ 0.26 per share from $ 0.29 million in revenue. For the full year, analysts predict revenues of $ 5.60 million, while looking forward to loss of $ 1.23 per share.
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products. It primarily focuses on liquid products, including injectable, oral liquid, and ophthalmic products. The company develops EM-100, an ophthalmic product for the treatment of allergic conjunctivitis; ET-202 and ET-203, which are injectable product candidates for use in the hospital setting; ET-103, an oral liquid product candidate for hypothyroidism; ET-101, ET-102, and ET-104, which are oral liquid product candidates for neurological indications; and CT-100, a synthetic corticotropin therapeutic candidate for rheumatoid arthritis.
